SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-23-000053
Filing Date
2023-08-04
Accepted
2023-08-03 19:28:03
Documents
88
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20230630.htm   iXBRL 10-Q 2189874
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2023630xq2.htm EX-31 19895
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2023630xq2.htm EX-32 9548
  Complete submission text file 0000318154-23-000053.txt   10691937

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20230630.xsd EX-101.SCH 66207
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20230630_cal.xml EX-101.CAL 67714
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20230630_def.xml EX-101.DEF 391134
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20230630_lab.xml EX-101.LAB 800585
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20230630_pre.xml EX-101.PRE 566858
82 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20230630_htm.xml XML 1932074
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 231141771
SIC: 2836 Biological Products, (No Diagnostic Substances)